Table 2.
Characteristics of APL patients in included studies
| Study | NO. | Induction | Age (years) | Sex (M-F) | Translocation |
|---|---|---|---|---|---|
| Zhang Y, et al (2016) | 103 | ATRA, ATO, Chemo | 14-74 | 60-43 | t(15;17) |
| Hou J, et.al (2017) | 216 | ATO | 7-80 | 105-111 | t(15;17) |
| H-H. Zhu, et al (2018) | 38 | ATO | 15-59 | 23-15 | t(15;17) |
| Xu F, et al (2017) | 163 | ATRA, ATO, Chemo | 15-54 | 91-72 | t(15;17) |
| H. Agis, et al (1999) | 1 | ATRA, ATO | 56 | 0-1 | t(15;17) |
| T.A. Colvin, et al
(2018) |
1 | ATRA, ATO | 78 | 1-0 | t(15;17) |
| Ishitsuka, et. al (2004) | 1 | ATO | 60 | 1-0 | t(15;17) |
M: Male, F: Female, ATRA: All Trans Retinoic Acid, ATO: Arsenic Trioxide, Chemo: Chemotherapy